Supreme Court Rejects Pharma Challenges to Drug Pricing, Whistleblower Law
The U.S. Supreme Court rejected appeals from major pharmaceutical companies, including Eli Lilly, challenging both a Civil War-era whistleblower law related to Medicaid fraud and the Biden administration's Medicare drug price negotiation program. This decision upholds government efforts to control drug costs and combat fraud.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Excellent (84/100)Sources
Supreme Court rejects Big Pharma appeals challenging negotiated drug prices in Medicare - CNN
Supreme Court rejects Big Pharma appeals challenging negotiated drug prices in Medicare CNN
Read full article →Supreme Court rejects Eli Lilly challenge to Civil War-era whistleblower law on Medicaid fraud
The justices rejected Lilly's appeal of a lower court's ruling, which upheld a $183 million judgment from a whistleblower lawsuit against the drugmaker for defrauding Medicaid
By John Kruzel
Read full article →Supreme Court to hear challenges over junior ministers
Two TDs are to take their challenges over super junior ministers attending Cabinet meetings to the Supreme Court.
Read full article →Eli Lilly whistleblower law challenge denied by Supreme Court
Read full article →NDLEA destroys two cannabis plantations, arrests four in Edo
The NDLEA Edo command destroyed two cannabis plantations and arrested four suspected drug traffickers in separate operations across the state this week. Read More: https://punchng.com/ndlea-destroys-two-cannabis-plantations-arrests-four-in-edo/
By Punch Newspapers
Read full article →Tweede Kamer rejects easing of military zero-tolerance drug policy
The Dutch Tweede Kamer has rejected any relaxation of the Defense Ministry’s strict zero-tolerance drug policy, with a majority voting Tuesday to adopt a motion from the PVV party.
By 88863
Read full article →
